ArticleBloodPublished
Ramantamig (JNJ-79635322), a novel T-cell-engaging trispecific antibody targeting BCMA, GPRC5D, and CD3, in multiple myeloma models
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Blood
- Published
- Topic
- Disease research
- Subject terms
- T-Lymphocytes; Cell Line, Tumor; Animals; Humans; Mice; Mice, SCID; Multiple Myeloma; Receptors, G-Protein-Coupled; Antibodies, Bispecific; Xenograft Model Antitumor Assays; B-Cell Maturation Antigen; CD3 Complex
- PubMed ID
- 41100731
- PubMed Central ID
- PMC13000934
- Open access
- Yes, open
- Added to directory
- Source checked